BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Bryant SE, Xiao G, Edwards M, Devous M, Gupta VB, Martins R, Zhang F, Barber R; Texas Alzheimer's Research and Care Consortium (TARCC). Biomarkers of Alzheimer's disease among Mexican Americans. J Alzheimers Dis 2013;34:841-9. [PMID: 23313927 DOI: 10.3233/JAD-122074] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Royall DR, Palmer RF. Thrombopoietin is associated with δ's intercept, and only in Non-Hispanic Whites. Alzheimers Dement (Amst) 2016;3:35-42. [PMID: 27239547 DOI: 10.1016/j.dadm.2016.02.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
2 O'Bryant SE, Edwards M, Zhang F, Johnson LA, Hall J, Kuras Y, Scherzer CR. Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study. Alzheimers Dement (Amst) 2019;11:374-82. [PMID: 31080873 DOI: 10.1016/j.dadm.2019.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 O'Bryant SE, Ferman TJ, Zhang F, Hall J, Pedraza O, Wszolek ZK, Como T, Julovich D, Mattevada S, Johnson LA, Edwards M, Hall J, Graff-Radford NR. A proteomic signature for dementia with Lewy bodies. Alzheimers Dement (Amst) 2019;11:270-6. [PMID: 30923734 DOI: 10.1016/j.dadm.2019.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
4 Gerstner JR, Lenz O, Vanderheyden WM, Chan MT, Pfeiffenberger C, Pack AI. Amyloid-β induces sleep fragmentation that is rescued by fatty acid binding proteins in Drosophila. J Neurosci Res 2017;95:1548-64. [PMID: 27320125 DOI: 10.1002/jnr.23778] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
5 Royall DR, Bishnoi RJ, Palmer RF; Alzheimer's Disease Neuroimaging Initiative. Blood-based protein predictors of dementia severity as measured by δ: Replication across biofluids and cohorts. Alzheimers Dement (Amst) 2019;11:763-74. [PMID: 31909176 DOI: 10.1016/j.dadm.2019.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Roberts RO, Aakre JA, Cha RH, Kremers WK, Mielke MM, Velgos SN, Geda YE, Knopman DS, Petersen RC. Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele. Front Aging Neurosci 2015;7:172. [PMID: 26441635 DOI: 10.3389/fnagi.2015.00172] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 O'Bryant SE, Zhang F, Johnson LA, Hall J, Edwards M, Grammas P, Oh E, Lyketsos CG, Rissman RA. A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease. J Alzheimers Dis 2018;66:97-104. [PMID: 30198872 DOI: 10.3233/JAD-180619] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
8 Royall DR, Palmer RF. δ scores predict mild cognitive impairment and Alzheimer's disease conversions from nondemented states. Alzheimers Dement (Amst) 2017;6:214-21. [PMID: 28378011 DOI: 10.1016/j.dadm.2017.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Johnson LA, Zhang F, Large S, Hall J, O'Bryant SE. The impact of comorbid depression-diabetes on proteomic outcomes among community-dwelling Mexican Americans with mild cognitive impairment. Int Psychogeriatr 2020;32:17-23. [PMID: 31658917 DOI: 10.1017/S1041610219001625] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Cunningham RL, Singh M, O'Bryant SE, Hall JR, Barber RC. Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease. J Alzheimers Dis 2014;40:563-73. [PMID: 24496073 DOI: 10.3233/JAD-131994] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
11 Burke SL, Naseh M, Rodriguez MJ, Burgess A, Loewenstein D. Dementia-Related Neuropsychological Testing Considerations in Non-Hispanic White and Latino/Hispanic Populations. Psychol Neurosci 2019;12:144-68. [PMID: 31649798 DOI: 10.1037/pne0000163] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 O'Bryant SE, Lista S, Rissman RA, Edwards M, Zhang F, Hall J, Zetterberg H, Lovestone S, Gupta V, Graff-Radford N, Martins R, Jeromin A, Waring S, Oh E, Kling M, Baker LD, Hampel H. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. Alzheimers Dement (Amst) 2016;3:27-34. [PMID: 27019866 DOI: 10.1016/j.dadm.2015.12.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
13 O'Bryant SE, Edwards M, Johnson L, Hall J, Gamboa A, O'jile J. Texas Mexican American adult normative studies: Normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers. Dev Neuropsychol 2018;43:1-26. [PMID: 29190120 DOI: 10.1080/87565641.2017.1401628] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
14 Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Sci Rep 2016;6:29078. [PMID: 27381087 DOI: 10.1038/srep29078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
15 O'Bryant SE, Johnson LA, Barber RC, Braskie MN, Christian B, Hall JR, Hazra N, King K, Kothapalli D, Large S, Mason D, Matsiyevskiy E, McColl R, Nandy R, Palmer R, Petersen M, Philips N, Rissman RA, Shi Y, Toga AW, Vintimilla R, Vig R, Zhang F, Yaffe K; HABLE Study Team. The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics. Alzheimers Dement (Amst) 2021;13:e12202. [PMID: 34189247 DOI: 10.1002/dad2.12202] [Reference Citation Analysis]
16 O'Bryant SE, Edwards M, Johnson L, Hall J, Villarreal AE, Britton GB, Quiceno M, Cullum CM, Graff-Radford NR. A blood screening test for Alzheimer's disease. Alzheimers Dement (Amst) 2016;3:83-90. [PMID: 27453929 DOI: 10.1016/j.dadm.2016.06.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
17 Burke SL, Rodriguez MJ, Barker W, Greig-Custo MT, Rosselli M, Loewenstein DA, Duara R. Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals with Normal Cognition, Mild Cognitive Impairment, and Dementia. J Int Neuropsychol Soc 2018;24:176-87. [PMID: 28918757 DOI: 10.1017/S1355617717000820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
18 Stickel AM, McKinnon AC, Matijevic S, Grilli MD, Ruiz J, Ryan L. Apolipoprotein E ε4 Allele-Based Differences in Brain Volumes Are Largely Uniform Across Late Middle Aged and Older Hispanic/Latino- and Non-Hispanic/Latino Whites Without Dementia. Front Aging Neurosci 2021;13:627322. [PMID: 33716715 DOI: 10.3389/fnagi.2021.627322] [Reference Citation Analysis]
19 Villarreal AE, O'Bryant SE, Edwards M, Grajales S, Britton GB; Panama Aging Research Initiative. Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics. Neurodegener Dis Manag 2016;6:203-13. [PMID: 27229914 DOI: 10.2217/nmt-2015-0009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
20 Rettberg JR, Dang H, Hodis HN, Henderson VW, St John JA, Mack WJ, Brinton RD. Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. Neurobiol Aging 2016;40:155-63. [PMID: 26973115 DOI: 10.1016/j.neurobiolaging.2016.01.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
21 Johnson LA, Cushing B, Rohlfing G, Edwards M, Davenloo H, D'Agostino D, Hall JR, O'Bryant SE. The Hachinski ischemic scale and cognition: the influence of ethnicity. Age Ageing 2014;43:364-9. [PMID: 24321843 DOI: 10.1093/ageing/aft189] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
22 Silzer T, Barber R, Sun J, Pathak G, Johnson L, O'Bryant S, Phillips N. Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans. PLoS One 2019;14:e0213527. [PMID: 30861027 DOI: 10.1371/journal.pone.0213527] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
23 Gonzales MM, Short MI, Satizabal CL, O' Bryant S, Tracy RP, Zare H, Seshadri S. Blood biomarkers for dementia in Hispanic and non-Hispanic White adults. Alzheimers Dement (N Y) 2021;7:e12164. [PMID: 33860071 DOI: 10.1002/trc2.12164] [Reference Citation Analysis]
24 Royall DR, Palmer RF; Alzheimer’s Disease Neuroimaging Initiative. A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative. J Alzheimers Dis 2019;67:67-79. [PMID: 30507569 DOI: 10.3233/JAD-171053] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Vidal-piñeiro D, Sørensen Ø, Blennow K, Capogna E, Halaas N, Idland A, Mowinckel A, Pereira J, Watne L, Zetterberg H, Walhovd K, Fjell A. Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.04.010] [Reference Citation Analysis]
26 O'Bryant SE, Zhang F, Silverman W, Lee JH, Krinsky-McHale SJ, Pang D, Hall J, Schupf N. Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome. Alzheimers Dement (Amst) 2020;12:e12033. [PMID: 32490140 DOI: 10.1002/dad2.12033] [Reference Citation Analysis]
27 Zhang F, Petersen M, Johnson L, Hall J, O'Bryant SE. Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer's Disease With High Performance Computing. Front Artif Intell 2021;4:798962. [PMID: 34957393 DOI: 10.3389/frai.2021.798962] [Reference Citation Analysis]
28 Royall DR, Palmer RF, Markides KS. Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort. J Gerontol B Psychol Sci Soc Sci 2017;72:947-55. [PMID: 26968639 DOI: 10.1093/geronb/gbw004] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
29 Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimers Res Ther 2018;10:98. [PMID: 30253800 DOI: 10.1186/s13195-018-0426-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
30 O'Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X, Como T, Reisch J, Huebinger RM, Graff-Radford N, Dickson D, Barber R, Hall J, O'Suilleabhain P, Grammas P. Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. J Alzheimers Dis 2014;42:1325-35. [PMID: 25024345 DOI: 10.3233/JAD-141041] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
31 Gongora-Rivera F, Cordero-Perez A, Gonzalez-Aquines A, Anaya-Escamilla A, Villarreal-Garza E, Espinosa-Ortega M, Salinas-Carmona MC, Ortiz-Jimenez X. Impaired Cerebral Vasomotor Reactivity in Alzheimer's Disease. Int J Alzheimers Dis 2018;2018:9328293. [PMID: 30271632 DOI: 10.1155/2018/9328293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Hall JR, Johnson LA, Zhang F, Petersen M, Toga AW, Shi Y, Mason D, Rissman RA, Yaffe K, O'Bryant SE; HABLE Study. Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study. Dement Geriatr Cogn Disord 2021;50:266-73. [PMID: 34569492 DOI: 10.1159/000518102] [Reference Citation Analysis]
33 Lennon JC, Aita SL, Bene VAD, Rhoads T, Resch ZJ, Eloi JM, Walker KA. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement 2021. [PMID: 34854531 DOI: 10.1002/alz.12509] [Reference Citation Analysis]
34 Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, Gupta S, O'Bryant S, Rembach A, Ames D, Ellis K, Fuller SJ, Brown B, Gardener SL, Fernando B, Bharadwaj P, Burnham S, Laws SM, Barron AM, Goozee K, Wahjoepramono EJ, Asih PR, Doecke JD, Salvado O, Bush AI, Rowe CC, Gandy SE, Masters CL. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. J Alzheimers Dis 2018;62:965-92. [PMID: 29562546 DOI: 10.3233/JAD-171145] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 16.3] [Reference Citation Analysis]
35 Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, Dreux S, Edland S, Esbensen A, Evered L, Ewers M, Fargo KN, Fortea J, Gonzalez H, Gustafson DR, Head E, Hendrix JA, Hofer SM, Johnson LA, Jutten R, Kilborn K, Lanctôt KL, Manly JJ, Martins RN, Mielke MM, Morris MC, Murray ME, Oh ES, Parra MA, Rissman RA, Roe CM, Santos OA, Scarmeas N, Schneider LS, Schupf N, Sikkes S, Snyder HM, Sohrabi HR, Stern Y, Strydom A, Tang Y, Terrera GM, Teunissen C, Melo van Lent D, Weinborn M, Wesselman L, Wilcock DM, Zetterberg H, O'Bryant SE; International Society to Advance Alzheimer's Research and Treatment, Alzheimer's Association. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimers Dement 2019;15:292-312. [PMID: 30555031 DOI: 10.1016/j.jalz.2018.09.009] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 27.0] [Reference Citation Analysis]
36 Rosselli M, Uribe IV, Ahne E, Shihadeh L. Culture, Ethnicity, and Level of Education in Alzheimer's Disease. Neurotherapeutics 2022. [PMID: 35347644 DOI: 10.1007/s13311-022-01193-z] [Reference Citation Analysis]
37 Royall DR, Palmer RF; Alzheimer’s Disease Neuroimaging Initiative (ADNI) and the Texas Alzheimer’s Research and Care Consortium (TARCC). Selection for depression-specific dementia cases with replication in two cohorts. PLoS One 2019;14:e0216413. [PMID: 31150419 DOI: 10.1371/journal.pone.0216413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]